Jonathan Young Akero Therapeutics, Inc. (AKRO) insider trading activity
Jonathan Young is Chief Operating Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 226,286 shares of AKRO, which is worth approximately $6.39 Million. The most recent transaction as insider was on Dec 27, 2022, when has been sold 12,500 shares (Common Stock) at a price of $49.57 per share, resulting in proceeds of $619,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
226K
8.33%
3M change
23.53%
12M change
Total Value Held
$6.39 Million
Jonathan Young Transaction History
JY
Jonathan Young
Chief Operating Officer
South San Francisco, CA